부산대학교 도서관

Röhn, Till A; Bachmann, Martin F

In Current Opinion in Immunology 2010 22(3):391-396

Gehlhaar, Patricia; Schaper-Gerhardt, Katrin; Gutzmer, Ralf; Hasler, Franziska; Röhn, Till A; Werfel, Thomas; Mommert, Susanne

Inflammation Research. 1/31/2025, Vol. 74 Issue 1, p1-13. 13p.

Jiang R; Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.; Graduate Program in Immunology, University of Michigan, Ann Arbor, MI, USA.; Bogle R; Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.; Xing X; Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.; Kirma J; Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.; Fox J; Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.; Harms PW; Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.; Do T; Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.; Billi AC; Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.; Kahlenberg JM; Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI, USA.; Modlin RL; Department of Dermatology, University of California Los Angeles (UCLA), Los Angeles, CA, USA.; Teles R; Department of Dermatology, University of California Los Angeles (UCLA), Los Angeles, CA, USA.; West J; Department of Dermatology, University of California Los Angeles (UCLA), Los Angeles, CA, USA.; Mangold A; Department of Dermatology, Mayo Clinic, Scottsdale, AZ, USA.; Zhang H; Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA.; Schneider MA; Immunology Disease Area, Novartis BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Bruno S; Immunology Disease Area, Novartis BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Roediger B; Immunology Disease Area, Novartis BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Martiny-Baron G; Immunology Disease Area, Novartis BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Tsoi LC; Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.; Hacini-Rachinel F; Immunology Disease Area, Novartis BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Röhn TA; Immunology Disease Area, Novartis BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Gudjonsson JE; Department of Dermatology, University of Michigan, Ann Arbor, MI, USA. johanng@med.umich.edu.; Graduate Program in Immunology, University of Michigan, Ann Arbor, MI, USA. johanng@med.umich.edu.; Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI, USA. johanng@med.umich.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Velcicky J; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland. juraj.velcicky@novartis.com.; Cremosnik G; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Scheufler C; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Meier P; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Wirth E; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Felber R; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Ramage P; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Schaefer M; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Kaiser C; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Lehmann S; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Kutil R; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Singeisen S; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Mueller-Ristig D; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Popp S; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Cebe R; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Lehr P; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Kaupmann K; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Erbel P; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Röhn TA; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Giovannoni J; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Dumelin CE; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland.; Martiny-Baron G; Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland. georg.martiny-baron@novartis.com.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Hacini-Rachinel F; BioMedical Research, Immunology Novartis Pharma AG, Basel, Switzerland.; Hauchard A; BioMedical Research, Immunology Novartis Pharma AG, Basel, Switzerland.; Bruno S; BioMedical Research, Immunology Novartis Pharma AG, Basel, Switzerland.; Paulat G; BioMedical Research, Immunology Novartis Pharma AG, Basel, Switzerland.; Cojean C; BioMedical Research, Immunology Novartis Pharma AG, Basel, Switzerland.; Loesle P; BioMedical Research, Immunology Novartis Pharma AG, Basel, Switzerland.; Schneider MA; BioMedical Research, Immunology Novartis Pharma AG, Basel, Switzerland.; Bourne M; BioMedical Research, Immunology Novartis Pharma AG, Basel, Switzerland.; Elain G; BioMedical Research, Immunology Novartis Pharma AG, Basel, Switzerland.; Roth L; BioMedical Research, Immunology Novartis Pharma AG, Basel, Switzerland.; Urban B; BioMedical Research, Immunology Novartis Pharma AG, Basel, Switzerland.; Viebrock S; BioMedical Research, Immunology Novartis Pharma AG, Basel, Switzerland.; Leon AO; BioMedical Research, Immunology Novartis Pharma AG, Basel, Switzerland.; Röhn TA; BioMedical Research, Immunology Novartis Pharma AG, Basel, Switzerland.; Loesche C; BioMedical Research, Immunology Novartis Pharma AG, Basel, Switzerland.; Werfel T; Department of Dermatology and Allergy Medizinische Hochschule Hannover, Hannover, Germany.; Thoma G; BioMedical Research, Global Discovery Chemistry Novartis Pharma AG, Basel, Switzerland.; Zerwes HG; BioMedical Research, Immunology Novartis Pharma AG, Basel, Switzerland.

Publisher: Munksgaard Country of Publication: Denmark NLM ID: 9301549 Publication Model: Print Cited Medium: Internet ISSN: 1600-0625 (Electronic) Linking ISSN: 09066705 NLM ISO Abbreviation: Exp Dermatol Subsets: MEDLINE

Röhn, Till A; Wagenknecht, Bettina; Roth, Wilfried; Naumann, Ulrike; Gulbins, Erich; Krammer, Peter H; Walczak, Henning; Weller, Michael

Oncogene. 7/12/2001, Vol. 20 Issue 31, p4128. 10p.

Loesche C; Translational Medicine, Novartis BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Picard D; Translational Medicine, Novartis BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Van Hoorick B; Clinical Pharmacology Unit, SGS, Antwerp, Belgium.; Schuhmann I; Biomarker Development, Novartis BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Jäger P; Immunology Disease Area, Novartis BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Klein K; PK Sciences, Novartis BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Schuhler C; Early Development Analytics, Novartis Pharma AG, Basel, Switzerland.; Thoma G; Global Discovery Chemistry, Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Markert C; Global Discovery Chemistry, Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Poller B; PK Sciences, Novartis BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Zamurovic N; Preclinical Safety, Novartis BioMedical Research, Basel, Switzerland.; Weiss HM; PK Sciences, Novartis BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Otto H; Immunology Disease Area, Novartis BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Fink M; Early Development Analytics, Novartis Pharma AG, Basel, Switzerland.; Röhn TA; Immunology Disease Area, Novartis BioMedical Research, Novartis Pharma AG, Basel, Switzerland.

Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE

Thoma G; Global Discovery Chemistry, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.; Miltz W; Global Discovery Chemistry, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.; Waelchli R; Global Discovery Chemistry, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.; Orain D; Global Discovery Chemistry, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.; Spanka C; Global Discovery Chemistry, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.; Decoret O; Global Discovery Chemistry, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.; Wolf RM; Global Discovery Chemistry, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.; Hurley B; Global Discovery Chemistry, Biomedical Research, Novartis Pharmaceuticals, Cambridge, Massachusetts 02139, United States.; Cheung AK; Global Discovery Chemistry, Biomedical Research, Novartis Pharmaceuticals, Cambridge, Massachusetts 02139, United States.; Sandham DA; Global Discovery Chemistry, Biomedical Research, Novartis Pharmaceuticals, Cambridge, Massachusetts 02139, United States.; Honda A; Global Discovery Chemistry, Biomedical Research, Novartis Pharmaceuticals, Cambridge, Massachusetts 02139, United States.; Tichkule R; Global Discovery Chemistry, Biomedical Research, Novartis Pharmaceuticals, Cambridge, Massachusetts 02139, United States.; Chen X; Global Discovery Chemistry, Biomedical Research, Novartis Pharmaceuticals, Cambridge, Massachusetts 02139, United States.; Patel T; Global Discovery Chemistry, Biomedical Research, Novartis Pharmaceuticals, Cambridge, Massachusetts 02139, United States.; Labbe-Giguere N; Global Discovery Chemistry, Biomedical Research, Novartis Pharmaceuticals, Cambridge, Massachusetts 02139, United States.; Tan KL; Global Discovery Chemistry, Biomedical Research, Novartis Pharmaceuticals, Cambridge, Massachusetts 02139, United States.; Springer C; Global Discovery Chemistry, Biomedical Research, Novartis Pharmaceuticals, Cambridge, Massachusetts 02139, United States.; Manchester J; Global Discovery Chemistry, Biomedical Research, Novartis Pharmaceuticals, Cambridge, Massachusetts 02139, United States.; Culshaw AJ; Global Discovery Chemistry, Novartis Horsham Research Centre, Horsham, West Sussex RH12 5AB, U.K.; Hunt P; Global Discovery Chemistry, Novartis Horsham Research Centre, Horsham, West Sussex RH12 5AB, U.K.; Srinivas H; Discovery Sciences, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.; Penno CA; Discovery Sciences, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.; Ferrand S; Discovery Sciences, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.; Numao S; Discovery Sciences, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.; Schopfer U; Discovery Sciences, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.; Jäger P; Immunology Disease Area, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.; Wack N; Immunology Disease Area, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.; Hasler F; Immunology Disease Area, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.; Urban B; Immunology Disease Area, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.; Sindelar M; Immunology Disease Area, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.; Loetscher P; Immunology Disease Area, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.; Kiffe M; PK Sciences, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.; Ren X; PK Sciences, Biomedical Research, Novartis Pharmaceuticals, East Hanover, New Jersey 07936, United States.; Nicklin P; Respiratory Disease Area, Novartis Horsham Research Centre, Horsham, West Sussex RH12 5AB, U.K.; White K; Global Health Disease Area, Biomedical Research, Novartis Pharmaceuticals, Cambridge, Massachusetts 02139, United States.; Subramanian K; Global Health Disease Area, Biomedical Research, Novartis Pharmaceuticals, Cambridge, Massachusetts 02139, United States.; Liu H; Global Health Disease Area, Biomedical Research, Novartis Pharmaceuticals, Cambridge, Massachusetts 02139, United States.; Growcott EJ; Global Health Disease Area, Biomedical Research, Novartis Pharmaceuticals, Cambridge, Massachusetts 02139, United States.; Röhn TA; Immunology Disease Area, Biomedical Research, Novartis Pharma AG, Basel 4002, Switzerland.

Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

Bier K; Immunology Disease Area, Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland. Electronic address: katharina.bier@novartis.com.; Senajova Z; Immunology Disease Area, Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Henrion F; Immunology Disease Area, Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Wang Y; Immunology Disease Area, Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Bruno S; Immunology Disease Area, Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Rauld C; Immunology Disease Area, Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Hörmann LC; Immunology Disease Area, Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Barske C; Immunology Disease Area, Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Delucis-Bronn C; Immunology Disease Area, Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Bergling S; Discovery Science, Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Altorfer M; Discovery Science, Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Hägele J; Discovery Science, Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Knehr J; Discovery Science, Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Junt T; Immunology Disease Area, Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Roediger B; Immunology Disease Area, Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Röhn TA; Immunology Disease Area, Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Kolbinger F; Immunology Disease Area, Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.

Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE

Thoma G; Global Discovery Chemistry, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Miltz W; Global Discovery Chemistry, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Srinivas H; Discovery Sciences, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Penno CA; Discovery Sciences, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Kiffe M; PK Sciences, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Gajewska M; PK Sciences, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Klein K; PK Sciences, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Evans A; Immunology Disease Area, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Beerli C; Immunology Disease Area, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Röhn TA; Immunology Disease Area, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.

Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

Thoma G; Global Discovery Chemistry, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Markert C; Global Discovery Chemistry, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Lueoend R; Global Discovery Chemistry, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Miltz W; Global Discovery Chemistry, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Spanka C; Global Discovery Chemistry, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Bollbuck B; Global Discovery Chemistry, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Wolf RM; Global Discovery Chemistry, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Srinivas H; Chemical Biology & Therapeutics, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Penno CA; Chemical Biology & Therapeutics, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Kiffe M; PK Sciences, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Gajewska M; PK Sciences, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Bednarczyk D; Discovery & Translational Lab, Biomedical Research, Novartis Pharma AG, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.; Wieczorek G; Immunology Disease Area, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Evans A; Immunology Disease Area, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Beerli C; Immunology Disease Area, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.; Röhn TA; Immunology Disease Area, Biomedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.

Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

Zouboulis CC; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.; Benhadou F; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Department of Dermatology, Hôpital Erasme, Universite Libre de Bruxelles, Bruxelles, Belgium.; Byrd AS; Department of Dermatology, Howard University College of Medicine, Washington, DC, USA.; Chandran NS; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Division of Dermatology, Department of Medicine, National University Hospital, Singapore.; Giamarellos-Bourboulis EJ; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece.; Fabbrocini G; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.; Frew JW; The Rockefeller University, New York, NY, USA.; Fujita H; Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan.; González-López MA; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Division of Dermatology, Hospital Universitario Marqués de Valdecilla, University of Cantabria, IDIVAL, Santander, Spain.; Guillem P; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Department of Surgery, Clinique du Val d'Ouest (Lyon), ResoVerneuil (Paris) and Groupe de Recherche en Proctologie de la Société Nationale Française de ColoProctologie, Paris, France.; Gulliver WPF; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Faculty of Medicine, Memorial University of Newfoundland, and NewLab Clinical Research Inc, St. John's, Canada.; Hamzavi I; Department of Dermatology, Henry Ford Hospital, Wayne State University, Detroit, MI, USA.; Hayran Y; Department of Dermatology, Ankara Numune Training and Research Hospital, Ankara, Turkey.; Hórvath B; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Department of Dermatology University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Hüe S; INSERM, Créteil, France.; Hunger RE; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Department of Dermatology, Inselspital, Bern University Hospital, Bern, Switzerland.; Ingram JR; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Department of Dermatology & Academic Wound Healing, Division of Infection and Immunity, Cardiff University, Cardiff, UK.; Jemec GBE; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.; Ju Q; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Department of Dermatology, RenJi Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.; Kimball AB; Department of Dermatology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.; Kirby JS; Department of Dermatology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA.; Konstantinou MP; Dermatology Department, Paul Sabatier University, University Hospital of Toulouse, Toulouse, France.; Lowes MA; The Rockefeller University, New York, NY, USA.; MacLeod AS; Department of Dermatology, Department of Immunology, Department of Molecular Genetics and Microbiology, Duke University, Durham, NC, USA.; Martorell A; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Department of Dermatology, Hospital of Manises, Valencia, Spain.; Marzano AV; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.; Matusiak Ł; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Department of Dermatology, Venereology and Allergology, Wrocław Medical University, Wrocław, Poland.; Nassif A; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Institut Pasteur, Paris, France.; Nikiphorou E; Centre for Rheumatic Diseases, King's College London, and Department of Rheumatology, King's College Hospital, London, UK.; Nikolakis G; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.; Nogueira da Costa A; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Translational Science and Experimental Medicine, Early Respiratory and Immunology, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Okun MM; Fort HealthCare, Fort Atkinson, WI, USA.; Orenstein LAV; Department of Dermatology, Emory University School of Medicine, Atlanta, GA, USA.; Pascual JC; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Alicante University General Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain.; Paus R; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.; Perin B; Division of Dermatology, University of Washington, Seattle, WA, USA.; Prens EP; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Röhn TA; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Szegedi A; Division of Dermatological Allergology, Department of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; Szepietowski JC; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Department of Dermatology, Venereology and Allergology, Wrocław Medical University, Wrocław, Poland.; Tzellos T; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Department of Dermatology, Nordland Hospital Trust, Bodø, Norway.; Wang B; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Department of Dermatology, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; van der Zee HH; European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.

Publisher: Munksgaard Country of Publication: Denmark NLM ID: 9301549 Publication Model: Print Cited Medium: Internet ISSN: 1600-0625 (Electronic) Linking ISSN: 09066705 NLM ISO Abbreviation: Exp Dermatol Subsets: MEDLINE

Uluckan Ö; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland.; Bruno S; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland.; Wang Y; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland.; Wack N; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland.; Wilzopolski J; Institut für Pharmakologie und Toxikologie, Veterinärmedizin, Freie Universität Berlin, Koserstraße 20, 14195, Berlin, Germany; Bundesinstitut für Risikobewertung, Experimentelle Toxikologie und ZEBET, Diedersdorfer Weg 1, 12277, Berlin, Germany.; Goetschy JF; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland.; Delucis-Bronn C; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland.; Urban B; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland.; Fehlmann D; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland.; Stark H; Heinrich Heine University Düsseldorf, Institute of Pharmaceutical and Medicinal Chemistry, Universitätsstr. 1, 40225, Düsseldorf, Germany.; Hauchard A; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland.; Roussel E; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland.; Kempf D; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland.; Kaupmann K; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland.; Raulf F; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland.; Bäumer W; Institut für Pharmakologie und Toxikologie, Veterinärmedizin, Freie Universität Berlin, Koserstraße 20, 14195, Berlin, Germany.; Röhn TA; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland.; Zerwes HG; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland. Electronic address: hans-guenter.zerwes_ext@novartis.com.

Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE

Penno CA; Analytical Sciences & Imaging, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Wack N; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Laguerre C; Analytical Sciences & Imaging, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Hasler F; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Numao S; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Röhn TA; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland. till.roehn@novartis.com.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Macchiarella G; Biomarker Development (BMD), Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland; Biozentrum, Faculty of Sciences, University of Basel, Basel, Switzerland.; Cornacchione V; NIBR Biologics Center (NBC), Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Cojean C; Autoimmunity, Transplantation and Inflammation (ATI) Disease Area, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Riker J; Autoimmunity, Transplantation and Inflammation (ATI) Disease Area, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Wang Y; Autoimmunity, Transplantation and Inflammation (ATI) Disease Area, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Te H; Autoimmunity, Transplantation and Inflammation (ATI) Disease Area, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Ceci M; Autoimmunity, Transplantation and Inflammation (ATI) Disease Area, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Gudjonsson JE; Department of Dermatology, University of Michigan, Ann Arbor, Michigan, USA.; Gaulis S; Autoimmunity, Transplantation and Inflammation (ATI) Disease Area, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Goetschy JF; Autoimmunity, Transplantation and Inflammation (ATI) Disease Area, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Wollschlegel A; Autoimmunity, Transplantation and Inflammation (ATI) Disease Area, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Gass SK; Department of Plastic, Reconstructive & Aesthetic Surgery and Hand Surgery, University Hospital, University of Basel, Switzerland.; Oetliker-Contin S; Department of Plastic, Reconstructive & Aesthetic Surgery and Hand Surgery, University Hospital, University of Basel, Switzerland.; Wettstein-Ling B; Department of Plastic, Reconstructive & Aesthetic Surgery and Hand Surgery, University Hospital, University of Basel, Switzerland.; Schaefer DJ; Department of Plastic, Reconstructive & Aesthetic Surgery and Hand Surgery, University Hospital, University of Basel, Switzerland.; Meschberger P; Department of Surgery, Kantonsspital Baselland, Liestal, Switzerland.; de Roche R; Praxis beim Merian Iselin, Basel, Switzerland.; Osinga R; Department of Plastic, Reconstructive & Aesthetic Surgery and Hand Surgery, University Hospital, University of Basel, Switzerland; Praxis beim Merian Iselin, Basel, Switzerland.; Wieczorek G; Autoimmunity, Transplantation and Inflammation (ATI) Disease Area, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Naumann U; Chemical Biology and Therapeutics (CBT), Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Lehmann JCU; Autoimmunity, Transplantation and Inflammation (ATI) Disease Area, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Schubart A; Autoimmunity, Transplantation and Inflammation (ATI) Disease Area, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Hofmann A; Biotherapeutic and Analytical Technologies, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Roth L; Autoimmunity, Transplantation and Inflammation (ATI) Disease Area, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Florencia EF; Department of Dermatology, Erasmus University Medical Centre, Rotterdam, the Netherlands.; Loesche C; Translational Medicine, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Traggiai E; NIBR Biologics Center (NBC), Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Avrameas A; Biomarker Development (BMD), Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Prens EP; Department of Dermatology, Erasmus University Medical Centre, Rotterdam, the Netherlands.; Röhn TA; Autoimmunity, Transplantation and Inflammation (ATI) Disease Area, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Roediger B; Autoimmunity, Transplantation and Inflammation (ATI) Disease Area, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland. Electronic address: ben.roediger@novartis.com.

Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE

Röhn TA; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for Biomedical Research, Basel, Switzerland.; Numao S; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland.; Otto H; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for Biomedical Research, Basel, Switzerland.; Loesche C; Translational Medicine, Novartis Institutes for Biomedical Research, Basel, Switzerland.; Thoma G; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel, Switzerland.

Publisher: Taylor & Francis Country of Publication: England NLM ID: 101295755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1746-045X (Electronic) Linking ISSN: 17460441 NLM ISO Abbreviation: Expert Opin Drug Discov Subsets: MEDLINE

Markert C; Thoma G; Srinivas H; Bollbuck B; Lüönd RM; Miltz W; Wälchli R; Wolf R; Hinrichs J; Bergsdorf C; Azzaoui K; Penno CA; Klein K; Wack N; Jäger P; Hasler F; Beerli C; Loetscher P; Dawson J; Wieczorek G; Numao S; Littlewood-Evans A; Röhn TA

Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

Penno CA; Analytical Sciences & Imaging, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Jäger P; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Laguerre C; Analytical Sciences & Imaging, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Hasler F; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Hofmann A; Analytical Sciences & Imaging, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Gass SK; Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital, Basel, and University of Basel, Basel, Switzerland.; Wettstein-Ling B; Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital, Basel, and University of Basel, Basel, Switzerland.; Schaefer DJ; Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital, Basel, and University of Basel, Basel, Switzerland.; Avrameas A; Biomarker Development, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Raulf F; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Wieczorek G; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Lehmann JCU; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Loesche C; Translational Medicine, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Roth L; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; Röhn TA; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland. Electronic address: till.roehn@novartis.com.

Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE

Songhet P; Institute of Microbiology, D-BIOL, ETH Zürich, Zürich, Switzerland.; Barthel M; Röhn TA; Van Maele L; Cayet D; Sirard JC; Bachmann M; Kopf M; Hardt WD

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: Electronic Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Stephen TL; Institute for Medical Microbiology, Immunology and Hygiene, Medical Center, University of Cologne, Cologne, Germany.; Fabri M; Groneck L; Röhn TA; Hafke H; Robinson N; Rietdorf J; Schrama D; Becker JC; Plum G; Krönke M; Kropshofer H; Kalka-Moll WM

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: Print Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE